Automation index
How much of a Biochemist’s job can AI already do?
A protocol and a curve come earlier. An assay that says what it says does not.
This percentage does not predict how many people will lose their jobs.
Task comparison
IS WORK OVER?
Biochemist
24%
AI can already do 24% of this job.
#264 / 643
View rankingBiochemist
Where the time goes
Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.
The time saving for each task is estimated separately.
| Task | Share | AI | Points |
|---|---|---|---|
Protocols, curves and analysis.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 48% | +8.6 |
Bench, pipettes and assays.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 14% | +2.5 |
Team, paper and not dressing a gel.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 22% | +3.5 |
Quality, lots and documentation.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 28% | +4.5 |
Rules, waste and safety.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 16% | +2.6 |
Not publishing a result that does not replicate.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 14% | +2.2 |
| Total | 100% | 24% |
Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low
Skills and activities
- Protocols, curves and analysis
- Bench, pipettes and assays
- Team, paper and not dressing a gel
- Quality, lots and documentation
- Rules, waste and safety
- bioquimico
- biochemist
Sources for this job· O*NET 19-1021.00· ESCO/ISCO 2131
IS WORK OVER?
Clinical research associate
27%
#172 / 643
View rankingClinical research associate
Where the time goes
Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.
The time saving for each task is estimated separately.
| Task | Share | AI | Points |
|---|---|---|---|
Protocol, CRF and the monitoring visit.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 48% | +8.6 |
Source, the gap and the one that does not fit.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 40% | +6.4 |
Adverse event, the deadline and not delaying.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 22% | +3.5 |
Consent, the signature and the one who did not understand.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 28% | +4.5 |
The sponsor, the audit and not dressing the figure.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 14% | +2.5 |
Audit, and not leaving a made-up figure.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 12% | +1.9 |
| Total | 100% | 27% |
Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low
Skills and activities
- CRF
- monitoring
- adverse events
- informed consent
- source data
- trial audits
- clinical protocols
- site visits
Sources for this job· O*NET 11-9121.00· ESCO/ISCO 2131